Microvascular reactivity of in vitro blood perfused juxtamedullary nephrons from rats.

D. Casellas,P. Carmines,L. Navar

DOI: https://doi.org/10.1038/KI.1985.194

IF: 19.6

1985-11-01

Kidney International

Abstract:

What problem does this paper attempt to address?

Zinc Finger Nucleases as tools to understand and treat human diseases

David P. Davis,D. Stokoe

DOI: https://doi.org/10.1186/1741-7015-8-42

IF: 9.3

2010-07-01

BMC Medicine

Abstract:
[Angiotensin-Converting Enzyme Inhibitors Potentiate Subthreshold Preconditioning Through NO and Mitok(atp) Channel.].

Hong Zhang,Bei Zhang,Bo-Yu Tang,Ying-Ying Chen,Li Zhu,Yue-Liang Shen

DOI: https://doi.org/10.3321/j.issn:0371-0874.2005.04.007

2005-01-01

Abstract:The aim of the present study was to determine whether angiotensin-converting enzyme inhibitors (ACEI) could contribute to the protective effects of preconditioning, and to explore its underlying mechanism. The Langendorff model of isolated rat heart was used. Cardiac contractility and lactate dehydrogenase (LDH) in the coronary effluent were measured, and infarct area of hearts after 30 min of ischemia followed by 120 min of reperfusion was analyzed. We found that: (1) The subthreshold preconditioning (2 min of ischemia and 10 min of reperfusion), captopril (an ACEI with sulfhydryl groups) or perindoprilate (an ACEI without sulfhydryl groups) alone did not protect the hearts from being injured by 30 min of ischemia and 120 min of reperfusion. (2) However, the combination of captopril or perindoprilate with subthreshold preconditioning could decrease left ventricular end-diastolic pressure (LVEDP), increase left ventricular developed pressure (LVDP) and coronary flow compared with the subthreshold preconditioned group. The combination treatments also inhibited the release of LDH from ischemia/reperfusion hearts, and reduced the infarct area in ischemic heart after 2 h of reperfusion (P<0.05). (3) By using NOS inhibitor L-NAME (100 mumol/L) before combined administration of ACEI with subthreshold preconditioning, the protection effect triggered by the combination treatment was significantly reduced. Pretreatment of the hearts with mitochondrial ATP-sensitive potassium (mitoK(ATP)) channel inhibitor 5-HD (100 mumol/L) also abolished the protection effect (P<0.05). (4) Subthreshold preconditioning, captopril or perindoprilate alone could enhance the NO content in coronary effluent (P<0.05), but the combination of captopril or perindoprilate with subthreshold preconditioning could further augment the NO content compared with the subthreshold preconditioned group (P<0.05). The results indicate that ACEIs with or without sulfhydryl groups may potentiate the subthreshold preconditioning to trigger cardiac protection effect against the ischemia/reperfusion injury. This protection effect in the heart is possibly mediated by the generation of NO and the activation of mitoK(ATP) channel.
Cardioprotection of Ischemic Postconditioning Against Ischemia/reperfusion Injury in Isolated Rat Hearts

吕萍萍,朱立,郦阳明,陈莹莹,沈岳良

DOI: https://doi.org/10.3321/j.issn:1000-4718.2008.05.003

2008-01-01

Abstract:AIM:To investigate the protective role of postconditioning in myocardial ischemia/reperfusion in rats and its mechanisms.METHODS:Cardiac contractility was analyzed by the Langendorff method.Infarct size was determined by dual staining with triphenyltetrazolium chloride and Even's blue dye,and the cardiac arrhythmia was evaluated.postconditioning was conducted by 3 cycles of 30 s ischemia followed by 30 s of reperfusion at the beginning of subsequent persistent reperfusion.RESULTS:Left ventricular systolic pressure(LVSP)and maximal rise rate of ventricular pressure(+dp/dtmax)were higher during reperfusion in postconditioning group compared with control.postconditioning reduced the infarct size in ischemia/reperfusion rat hearts.The cardiac arrhythmia score was decreased in postconditioning group in the first 10 min of reperfusion followed by ischemia compared to control group.postconditioning had similar cardioprotective effect as preconditioning.5-HD,a selective mitochondrial ATP-sensitive potassium channel(mitoKATP)inhibitor,blocked the amelioration of contract function provided by postconditioning.It also abolished the protective effect of postconditioning on cardiac arrhythmia score and infarct size.CONCLUSION:The results show that postconditioning has cardioprotective effect and attenuates reperfusion injury in ischemic heart.The effect might be partly through the activation of mitoKATP channel.
[COX-2 or Nnos Mediates Cardioprotection During the Final Stage of the Late Phase of Ischemic Preconditioning].

Qing Xu,Bie Tang,Ning Zhang,Lihua Song,Zhiqin Zhang,Yingying Chen

DOI: https://doi.org/10.3321/j.issn:1001-5515.2008.06.037

2008-01-01

Journal of Biomedical Engineering

Abstract:The aim of the present studies was to investigate the cardioprotection of late IP at 72 h and determine the involvement of iNOS, nNOS and COX-2 in this protection. Conscious rabbits were preconditioned with three cycles of 5-minute coronary occlusion/5-minute reperfusion. The myocardial infarct area in the rabbits preconditioned 72 h earlier was significantly smaller than that in control rabbits. The activity of lactate dehydrogenase (LDH) and the level of 6-Keto-PGF1alpha in the rabbits preconditioned 72 h earlier were lower than those in control rabbits. The left ventricular systolic pressure (LVSP) and maximal velocity of contraction and relaxation (+/- dP/dtmax) were improved in rabbits preconditioned 72 h earlier. The nNOS-selective inhibitors N-propyl-L-arginine and selective cyclooxygenase-2 (COX-2) inhibitor celecoxib completely blocked the protection of late IP at 72 h, whereas the iNOS selective inhibitor S-methybisothiourea had no effect. In conclusion, the cardioprotection observed in the final stage of late IP (72 hours) is mediated by nNOS or COX-2, but not by iNOS.
Ischemic Postconditioning Protects the Heart Against Ischemia–reperfusion Injury Via Neuronal Nitric Oxide Synthase in the Sarcoplasmic Reticulum and Mitochondria

L Hu,J Wang,H Zhu,X Wu,L Zhou,Y Song,S Zhu,M Hao,C Liu,Y Fan,Y Wang,Q Li

DOI: https://doi.org/10.1038/cddis.2016.108

2016-01-01

Cell Death and Disease

Abstract:As a result of its spatial confinement in cardiomyocytes, neuronal nitric oxide synthase (nNOS) is thought to regulate mitochondrial and sarcoplasmic reticulum (SR) function by maintaining nitroso-redox balance and Ca(2+) cycling. Thus, we hypothesize that ischemic postconditioning (IPostC) protects hearts against ischemic/reperfusion (I/R) injury through an nNOS-mediated pathway. Isolated mouse hearts were subjected to I/R injury in a Langendorff apparatus, H9C2 cells and primary neonatal rat cardiomyocytes were subjected to hypoxia/reoxygenation (H/R) in vitro. IPostC, compared with I/R, decreased infarct size and improved cardiac function, and the selective nNOS inhibitors abolished these effects. IPostC recovered nNOS activity and arginase expression. IPostC also increased AMP kinase (AMPK) phosphorylation and alleviated oxidative stress, and nNOS and AMPK inhibition abolished these effects. IPostC increased nitrotyrosine production in the cytosol but decreased it in mitochondria. Enhanced phospholamban (PLB) phosphorylation, normalized SR function and decreased Ca(2+) overload were observed following the recovery of nNOS activity, and nNOS inhibition abolished these effects. Similar effects of IPostC were demonstrated in cardiomyocytes in vitro. IPostC decreased oxidative stress partially by regulating uncoupled nNOS and the nNOS/AMPK/peroxisome proliferator-activated receptor gamma coactivator 1 alpha/superoxide dismutase axis, and improved SR function through increasing SR Ca(2+) load. These results suggest that IPostC protected hearts against I/R injury via an nNOS-mediated pathway.
Increased protein S-nitrosylation in mitochondria: a key mechanism of exercise-induced cardioprotection

Doria Boulghobra,Mathilde Dubois,Béatrice Alpha-Bazin,Florence Coste,Maxime Olmos,Sandrine Gayrard,Isabelle Bornard,Gregory Meyer,Jean-Charles Gaillard,Jean Armengaud,Cyril Reboul

DOI: https://doi.org/10.1007/s00395-021-00906-3

IF: 12.416

2021-12-01

Basic Research in Cardiology

Abstract:Endothelial nitric oxide synthase (eNOS) activation in the heart plays a key role in exercise-induced cardioprotection during ischemia–reperfusion, but the underlying mechanisms remain unknown. We hypothesized that the cardioprotective effect of exercise training could be explained by the re-localization of eNOS-dependent nitric oxide (NO)/S-nitrosylation signaling to mitochondria. By comparing exercised (5 days/week for 5 weeks) and sedentary Wistar rats, we found that exercise training increased eNOS level and activation by phosphorylation (at serine 1177) in mitochondria, but not in the cytosolic subfraction of cardiomyocytes. Using confocal microscopy, we confirmed that NO production in mitochondria was increased in response to H2O2 exposure in cardiomyocytes from exercised but not sedentary rats. Moreover, by S-nitrosoproteomic analysis, we identified several key S-nitrosylated proteins involved in mitochondrial function and cardioprotection. In agreement, we also observed that the increase in Ca2+ retention capacity by mitochondria isolated from the heart of exercised rats was abolished by exposure to the NOS inhibitor L-NAME or to the reducing agent ascorbate, known to denitrosylate proteins. Pre-incubation with ascorbate or L-NAME also increased mitochondrial reactive oxygen species production in cardiomyocytes from exercised but not from sedentary animals. We confirmed these results using isolated hearts perfused with L-NAME before ischemia–reperfusion. Altogether, these results strongly support the hypothesis that exercise training increases eNOS/NO/S-nitrosylation signaling in mitochondria, which might represent a key mechanism of exercise-induced cardioprotection.

cardiac & cardiovascular systems
Abstract W P109: Nitrosative Stress Preconditioning Ameliorated Neurovascular Injury in Stroke

Rongrong Tao,Huan Wang,Quan Jiang,Yingmei Lu,Feng Han

DOI: https://doi.org/10.1161/str.46.suppl_1.wp109

IF: 10.17

2015-01-01

Stroke

Abstract:Objective: Ischemic preconditioning (IPC) serves as a protective role in improving ischemic tolerance to subsequent severe stroke. Understanding the mechanisms underlying IPC-induced neuroprotection is essential to reveal potential therapeutic targets of ischemia attack. Here, we tested the hypothesis that moderate level flux of nitrosative stress contributes to IPC-associated neurovascular protection in mice subjected to ischemia-reperfusion injury. Methods: IPC was modeled in WT or eNOS -/- mice with two cycles of 5-min ischemia and 30-min reperfusion. 24h-reperfusion later, mice were subjected to 2h-transient middle cerebral artery occlusion (tMCAO) and neurological deficits, infarct volume, blood-brain barrier (BBB) permeability as well as neurovascular damage-related protein expression were evaluated 24 h later. Peroxynitrite donor SIN-1 preconditioning in brain and knockout of eNOS were further performed to determine the role of nitrosative stress during ischemic preconditioning. Results: IPC treatment ameliorated neurological dysfunction after cerebral ischemia compared to the tMCAO group without IPC, which was accompanied by a reduction of infract volume, evans blue leakage from BBB and MMP9 activation. In contract, inhibition of nitrosative stress by eNOS deficiency blocked the benefits of IPC on neurovascular protection during ischemic stroke. SIN-1 preconditioning at 0.5 mM significantly decreased neurological deficit scores and infarct volume after ischemic stroke. While both of 0.1 mM and 2 mM SIN-1 failed to active cell survival programs against ischemic injury. Conclusion: Nitrosative stress at moderate level is a key mediator of IPC-associated cell survival response and neurovascular protection during ischemic insult, thus implicating a novel therapeutic approach that selectively targeting nitrosative stress to active cell survival response during adaptive phase and ameliorate prolonged ischemic damage during later phase in stroke.
Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model.

Se-Chan Kim,Shuijing Wu,Xiangming Fang,Jens Neumann,Lars Eichhorn,Grigorij Schleifer,Olaf Boehm,Rainer Meyer,Stilla Frede,Andreas Hoeft,Georg Baumgarten,Pascal Knuefermann

DOI: https://doi.org/10.1016/j.lfs.2014.09.029

IF: 6.78

2014-01-01

Life Sciences

Abstract:AIMS:Toll-like receptor (TLR)9 ligand CpG-oligodeoxynucleotide (CpG-ODN) exerts preconditioning in myocardial ischemia/reperfusion. We hypothesized a postconditioning effect of CpG-ODN in a murine closed-chest model of myocardial infarction. MATERIALS AND METHODS:C57BL/6 (12 weeks, male, WT) mice were instrumented at the left anterior descending artery, then allowed 5d of recovery before 30 min ischemia. Treatments comprised: 1) PBS: 250 μl phosphate buffer solution intraperitoneally 5 min before reperfusion and 2) IPC (ischemic postconditioning): 3 twenty-second reperfusion and occlusion episodes at the end of ischemia 3) CpG-ODN: 1668 thioate 0.2 μmol/kg BW intraperitoneally 5 min before reperfusion. Infarct size was assessed via triphenyltetrazolium chloride (TTC) staining after 2 and 24h reperfusion. Myocardial mRNA-expression of cytokines was measured using real-time PCR after 2h reperfusion. Phosphatidylinositol-3 kinase (PI3K)-inhibitor wortmannin was injected intraperitoneally in WT 15 min before postconditioning and PBS in each group. Cardiac function in WT was assessed with a left-ventricular pressure-volume catheter at 24h reperfusion. KEY FINDINGS:Following 30 min ischemia and 2h reperfusion, infarct size was diminished by 90% in WT postconditioned with CpG-ODN (2.4 ± 1.55 IS/AAR%) and IPC (1.98 ± 1.03 IS/AAR%) compared to PBS mice (23.2 ± 3.97 IS/AAR%). Infarct size increased following 24h reperfusion but the differences remained robust. Expression of TNF-α and IL-10 was increased in CpG-ODN. Wortmannin abolished the postconditioning effect of CpG-ODN and IPC. Ejection fraction and preload-recruitable stroke work were significantly greater in CpG-ODN mice. SIGNIFICANCE:CpG-ODN confers postconditioning via activation of TLR9. Cardiac function is preserved following CpG-ODN postconditioning. The PI3K -inhibitor wortmannin attenuates CpG-ODN postconditioning.
Abstract 4146997: S-nitrosylation of Aconitase-2 Facilitates Coronary Microembolization-induced Cardiac Injury by Suppressing Iron-sulfur Cluster Assembly

Ao Chen,Yan Xia,Xinyu Che,Zhangwei Chen,Juying Qian,Junbo Ge

DOI: https://doi.org/10.1161/circ.150.suppl_1.4146997

IF: 37.8

2024-01-01

Circulation

Abstract:Background: Coronary microembolization (CME) is a common reason for periprocedural myocardial infarction after coronary interventions. S-nitrosylation (SNO), a prototypic redox-based posttranslational modification, is involved in the pathogenesis of several cardiovascular diseases. Purpose: To explore the role of SNO of aconitase-2 (ACO2) in CME-induced cardiac injury, as well as the mechanism by which SNO-ACO2 modulates myocardial injury in response to CME. Methods: CME models were established in C57BL/6J mice by injecting 300,000 polyethylene microspheres (diameter 9 µm) into the left ventricle chamber with the occlusion of the ascending aorta. S-nitrosylated proteins and SNO sites of ACO2 were identified through LC-MS/MS analysis. De-nitrosylation of ACO2 was achieved by the mutation of SNO site or overexpression of the de-nitrosylation enzyme thioredoxin 1 (TRX1). Interacting effectors of SNO-ACO2 were screened through LC-MS/MS and confirmed by coimmunoprecipitation. Neonatal rat ventricular myocytes (NRVMs) were used for ACO2 enzyme activity analysis, mitochondrial morphology and function. Results: Cardiac injury was exacerbated by CME as demonstrated by impaired cardiac contractile function, increased fibrosis, microinfarct size. We identified 789 S-nitrosylated proteins in CME mouse hearts, and ACO2 is one of the highly S-nitrosylated proteins. The increased level of SNO-ACO2 was verified by immunoblot assay in CME mouse hearts and hypoxia-stimulated NRVMs. SNO site of ACO2 at cysteine 126 was identified by LC-MS/MS and confirmed in NRVMs. De-nitrosylation of ACO2 by the mutation of cysteine 126 or overexpression of TRX1 both greatly improved the activity of ACO2 by 39.7% and 31.4% respectively, further restored the mitochondrial function, and attenuated CME-induced cardiac injury. Mechanistically, SNO-ACO2 at cysteine 126 suppressed the interaction between ACO2 and NFU1, an iron-sulfur (Fe-S) cluster scaffold protein. The dissociation from NFU1 deprived ACO2 of the Fe-S cluster and the enzyme activity, thereby promoting the disruption of the mitochondrial tricarboxylic acid cycle and cardiac injury. Conclusions: Our data defined a previously unrecognized role of SNO-ACO2 in CME-induced cardiac injury. We demonstrated that SNO-ACO2 at cysteine 126 disrupted ACO2/NFU1 interaction to exacerbate myocardial injury after CME. Our results suggested that de-nitrosylation of ACO2 may provide a new therapeutic target for the treatment of CME.
S-nitrosylation of Aconitase-2 Facilitates Coronary Microembolization-Induced Cardiac Injury by Suppressing Iron-Sulfur Cluster Assembly

A Chen,Z W Chen,Y Xia,X Y Che,Z Yang,D B Lu,J Q Ma,J Y Qian,J B Ge

DOI: https://doi.org/10.1093/eurheartj/ehae666.3721

IF: 39.3

2024-01-01

European Heart Journal

Abstract:Abstract Background Coronary microembolization (CME) is a common reason for periprocedural myocardial infarction after coronary interventions. S-nitrosylation (SNO), a prototypic redox-based posttranslational modification, is involved in the pathogenesis of several cardiovascular diseases. Purpose To explore the role of SNO of aconitase-2 (ACO2) in CME-induced cardiac injury, as well as the mechanism by which SNO-ACO2 modulates myocardial injury in response to CME. Methods CME models were established in C57BL/6J mice by injecting 300,000 polyethylene microspheres (diameter 9 µm) into the left ventricle chamber with the occlusion of the ascending aorta. Cardiac function was evaluated by echocardiography. Histological and serum analysis was performed to evaluate myocardial injury. Myocardial samples were scanned for S-nitrosylated proteins using biotin-switch procedures and liquid chromatography with tandem mass spectrometry (LC-MS/MS) analysis. SNO sites of ACO2 were further identified through LC-MS/MS. De-nitrosylation of ACO2 was achieved by the mutation of SNO site or overexpression of the de-nitrosylation enzyme thioredoxin 1 (TRX1). Interacting effectors of SNO- ACO2 were screened through LC-MS/MS and confirmed by coimmunoprecipitation. Neonatal rat ventricular myocytes (NRVMs) were used for in vitro study. The cellular ACO2 activity was analysed using an ACO2 enzyme activity assay kit. Mitochondrial morphology and function were assessed by fluorescent staining and mitochondrial stress testing. Results Cardiac injury was exacerbated by CME as demonstrated by impaired cardiac contractile function, morphological changes, and increased fibrosis, microinfarct size and serum troponin I level. We identified 789 S-nitrosylated proteins in CME mouse hearts, and ACO2 is one of the highly S-nitrosylated proteins. The increased level of SNO-ACO2 was verified by immunoblot assay in CME mouse hearts and hypoxia-stimulated NRVMs. SNO site of ACO2 at cysteine 126 was identified by LC-MS/MS and confirmed in NRVMs. De-nitrosylation of ACO2 by the mutation of cysteine 126 or overexpression of TRX1 both greatly improved the activity of ACO2 by 39.7% and 31.4% respectively, furthermore restored the mitochondrial function, and attenuated CME-induced cardiac injury. Mechanistically, SNO-ACO2 at cysteine 126 suppressed the interaction between ACO2 and NFU1, an iron-sulfur (Fe-S) cluster scaffold protein. The dissociation from NFU1 deprived ACO2 of the Fe-S cluster and the enzyme activity, thereby promoting the disruption of the mitochondrial tricarboxylic acid cycle and cardiac injury. Conclusions Our data defined a previously unrecognized role of SNO-ACO2 in CME-induced cardiac injury. We demonstrated that SNO-ACO2 at cysteine 126 disrupted ACO2/NFU1 interaction to exacerbate myocardial injury after CME. Our results suggested that de-nitrosylation of ACO2 may provide a new therapeutic target for the treatment of CME.
Pretreatment with the nitric oxide donor SNAP or nerve transection blocks humoral preconditioning by remote limb ischemia or intra-arterial adenosine

Tor Steensrud,Jing Li,Xiaojing Dai,Cedric Manlhiot,Rajesh K Kharbanda,Michael Tropak,Andrew Redington

DOI: https://doi.org/10.1152/ajpheart.00396.2010

Abstract:We have previously shown that remote ischemic preconditioning (rIPC) by transient limb ischemia leads to the release of a circulating factor(s) that induces potent myocardial protection. Intra-arterial injection of adenosine into a limb also leads to cardioprotection, but the mechanism of its signal transduction is poorly understood. Eleven groups of rabbits received saline control or rIPC or adenosine administration with additional pretreatment with the nitric oxide (NO) synthase blocker N(G)-nitro-l-arginine methyl ester, the NO donor S-nitroso-N-acetylpenicillamine, its non-NO-donating derivative N-acetylpenicillamine, or femoral nerve section. Blood was then drawn from each animal, and the dialysate of the plasma was used to perfuse a naïve heart from an untreated donor. Infarct size was measured after 30 min of global ischemia and 120 min reperfusion. When compared with that of the control, mean infarct size was significantly smaller in groups treated with rIPC alone (P < 0.01) and intra-arterial adenosine (P < 0.01). Pretreatment with N(G)-nitro-l-arginine methyl ester or N-acetylpenicillamine did not affect the level of protection induced by rIPC (P = not significant, compared with rIPC alone) or intra-arterial adenosine (P = not significant, compared with intra-arterial adenosine alone), but prior femoral nerve transection or pretreatment with S-nitroso-N-acetylpenicillamine abolished the cardioprotective effect of intra-arterial adenosine and rIPC. Intra-arterial adenosine, like rIPC, releases a blood-borne cardioprotective factor(s) that is dependent on an intact femoral nerve and is inhibited by pretreatment with a NO donor. These results may be important when designing or assessing the results of clinical trials of adenosine or rIPC cardioprotection, where NO donors are used as part of therapy.
Cardioprotective PKG-independent NO signaling at reperfusion

Michael V Cohen,Xi-Ming Yang,Yanping Liu,Nataliya V Solenkova,James M Downey

DOI: https://doi.org/10.1152/ajpheart.00527.2010

Abstract:Cell models of ischemic preconditioning (IPC) indicate nitric oxide (NO) is involved in protection accruing during reoxygenation but disagree whether it acts through PKG. Using a more relevant intact heart model, we studied isolated rabbit hearts subjected to 30-min coronary artery occlusion/120-min reperfusion. We previously found protection from PKG activator 8-(4-chlorophenylthio)-guanosine 3',5'-cyclic monophosphate (CPT-cGMP) at reperfusion was blocked by A(2b) adenosine receptor (A(2b)AR), ERK, or phosphatidylinositol 3-kinase (PI3-kinase) blockers. In this investigation A(2b)AR agonist BAY 60-6583 or CPT-cGMP at reperfusion reduced infarction comparably to IPC. Their protection was abrogated by N(ω)-nitro-l-arginine methyl ester (l-NAME), suggesting a PKG-independent NO synthase in IPC's mediator pathway downstream of PKG and A(2b)AR. NO donor S-nitroso-N-acetyl-d,l-penicillamine (SNAP) at reperfusion also protected. This protection was not blocked by PI3-kinase inhibitor wortmannin or ERK antagonist PD-98059, suggesting NO acted downstream of these kinases. Protection from SNAP was not affected by mitochondrial ATP-sensitive K(+) channel closer 5-hydroxydecanoate, PKC antagonist chelerythrine, reactive oxygen species scavenger N-2-mercaptopropionylglycine, or soluble guanylyl cyclase antagonist 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). Absence of ODQ effect indicated NO was acting independently of PKG. BAY 58-2667, a soluble guanylyl cyclase activator, was protective, and l-NAME blocked its infarct-sparing effect, indicating a second signaling event dependent on NO generation but independent of PKG. SB216763, a blocker of glycogen synthase kinase-3β (GSK-3β), decreased infarct size, and its infarct-sparing effect was not affected by l-NAME, suggesting GSK-3β acted downstream or independently of NO. Hence, NO signaling occurs in IPC's mediator pathway downstream of Akt and ERK, and its protection is independent of PKG.
Ischemic Postconditioning Relieves Cerebral Ischemia and Reperfusion Injury Through Activating T-LAK Cell–Originated Protein Kinase/Protein Kinase B Pathway in Rats

Haiping Zhao,Rongliang Wang,Zhen Tao,Li Gao,Feng Yan,Zhi Gao,Xiangrong Liu,Xunming Ji,Yumin Luo

DOI: https://doi.org/10.1161/strokeaha.114.006135

IF: 10.17

2014-01-01

Stroke

Abstract:BACKGROUND AND PURPOSE:Ischemic postconditioning (IPostC) protects against ischemic brain injury. To date, no study has examined the role of T-LAK-cell-originated protein kinase (TOPK) in IPostC-afforded neuroprotection. We explored the molecular mechanism related with TOPK in antioxidant effect of IPostC against ischemia/reperfusion.METHODS:Focal ischemia was induced in rats by transient middle cerebral artery occlusion. Reactive oxygen species production in the peri-infarct cortex was detected using dihydroethidium. Malondialdehyde, as a marker of lipid peroxidation, and 3-nitrotyrosine, as a marker of protein oxidation, were detected by ELISA. The expression or location of antioxidant proteins and signal molecules TOPK, phosphatase, and tensin homolog, and Akt was analyzed by Western blotting and immunofluorescence.RESULTS:Our results revealed that IPostC relieved transient middle cerebral artery occlusion-induced oxidative damage by reducing reactive oxygen species, malondialdehyde, and 3-nitrotyrosine accumulation in the peri-infarct cortex and raised levels of antioxidants perioxiredoxin-1, peroxiredoxin-2, and thioredoxin-1. In addition, IPostC increased p-AKT and p-TOPK levels, which colocalized in neural cells. In vitro TOPK knockdown by small interfering RNA decreased the levels of antioxidants peroxiredoxin-1, thioredoxin, and manganese superoxide dismutase activity in PC12 cells. In vivo intracerebroventricular injection of TOPK small interfering RNA reversed IPostC-induced neuroprotection by increasing infarct volume and nitric oxide content and reducing manganese superoxide dismutase activity. Moreover, IPostC-evoked Akt activation was blocked by TOPK small interfering RNA in vivo, but the decreased phosphorylated phosphatase and tensin homolog level in ischemia/reperfusion was not influenced by IPostC or by TOPK small interfering RNA treatment.CONCLUSIONS:Our results suggest that the antioxidative effects of TOPK/Akt might contribute to the neuroprotection of IPostC treatment against transient middle cerebral artery occlusion.
Nitric Oxide Regulation of Myocardial O-2 Consumption and Hep Metabolism

JY Zhang,GR Gong,Y Ye,T Guo,A Mansoor,QS Hu,K Ochiai,JB Liu,XH Wang,YR Cheng,N Iverson,J Lee,AHL From,K Ugurbil,RJ Bache

DOI: https://doi.org/10.1152/ajpheart.00518.2004

2005-01-01

Abstract:NO and O(2) compete at cytochrome-c oxidase, thus potentially allowing NO to modulate mitochondrial respiration. We previously observed a decrease of myocardial phosphocreatine (PCr)/ATP during very high cardiac work states, corresponding to an increase in cytosolic free ADP. This study tested the hypothesis that NO inhibition of respiration contributes to this increase of ADP. Infusion of dobutamine + dopamine (DbDp, each 20 microg.kg(-1).min(-1) iv) to more than double myocardial oxygen consumption (MVo(2)) in open-chest dogs caused a decrease of myocardial PCr/ATP measured with (31)P NMR from 2.04 +/- 0.09 to 1.85 +/- 0.08 (P < 0.05). Inhibition of NO synthesis with N(omega)-nitro-L-arginine (L-NNA), while catecholamine infusion continued, caused PCr/ATP to increase to the control value. In a second group of animals, L-NNA administered before catecholamine stimulation (reverse intervention of the first group) increased PCr/ATP during basal conditions. In these animals L-NNA did not prevent a decrease of PCr/ATP at the high cardiac work state but, relative to MVo(2), PCr/ATP was significantly higher after L-NNA. In a third group of animals, pharmacological coronary vasodilation with carbochromen was used to prevent changes in coronary flow that might alter endothelial NO production. In these animals L-NNA again restored depressed myocardial PCr/ATP during catecholamine infusion. The finding that inhibition of NO production increased PCr/ATP suggests that during very high work states NO inhibition of mitochondrial respiration requires ADP to increase to drive oxidative phosphorylation.
The dynamic detection of NO during the ischemic postconditioning against global cerebral ischemia/reperfusion injury.

Kezhou Liu,Ming Yan,Xiaoxiang Zheng,Yong Yang

DOI: https://doi.org/10.1016/j.niox.2014.02.002

IF: 4.898

2014-01-01

Nitric Oxide

Abstract:•We in vivo detected NO in rat hippocampus during the ischemic postconditioning.•We compared the effect of different postconditioning methods and got the best one.•The best postconditioning method induced large NO synthesis with a slow speed.•NO is a reliable candidate in mediating ischemic postconditioning neuroprotection.
S-nitrosylation of AMPKγ impairs coronary collateral circulation and disrupts VSMC reprogramming

Wenwu Bai,Tao Guo,Han Wang,Bin Li,Quan Sun,Wanzhou Wu,Jiaxiong Zhang,Jipeng Zhou,Jingmin Luo,Moli Zhu,Junxiu Lu,Peng Li,Bo Dong,Shufang Han,Xinyan Pang,Guogang Zhang,Yongping Bai,Shuangxi Wang

DOI: https://doi.org/10.1038/s44319-023-00015-3

Abstract:Collateral circulation is essential for blood resupply to the ischemic heart, which is dictated by the contractile phenotypic restoration of vascular smooth muscle cells (VSMC). Here we investigate whether S-nitrosylation of AMP-activated protein kinase (AMPK), a key regulator of the VSMC phenotype, impairs collateral circulation. In rats with collateral growth and development, nitroglycerin decreases coronary collateral blood flow (CCBF), inhibits vascular contractile phenotypic restoration, and increases myocardial infarct size, accompanied by reduced AMPK activity in the collateral zone. Nitric oxide (NO) S-nitrosylates human recombinant AMPKγ1 at cysteine 131 and decreases AMP sensitivity of AMPK. In VSMCs, exogenous expression of S-nitrosylation-resistant AMPKγ1 or deficient NO synthase (iNOS) prevents the disruption of VSMC reprogramming. Finally, hyperhomocysteinemia or hyperglycemia increases AMPKγ1 S-nitrosylation, prevents vascular contractile phenotypic restoration, reduces CCBF, and increases the infarct size of the heart in Apoe-/- mice, all of which is rescued in Apoe-/-/iNOSsm-/- mice or Apoe-/- mice with enforced expression of the AMPKγ1-C130A mutant following RI/MI. We conclude that nitrosative stress disrupts coronary collateral circulation during hyperhomocysteinemia or hyperglycemia through AMPK S-nitrosylation.
Ischemic Postconditioning Diminishes Matrix Metalloproteinase 9 Expression and Attenuates Loss of the Extracellular Matrix Proteins in Rats Following Middle Cerebral Artery Occlusion and Reperfusion

Xiang-Rong Liu,Mei Luo,Feng Yan,Chen-Cheng Zhang,Si-Jie Li,Hai-Ping Zhao,Xun-Ming Ji,Yu-Min Luo

DOI: https://doi.org/10.1111/j.1755-5949.2012.00366.x

2012-01-01

CNS Neuroscience & Therapeutics

Abstract:Aims Ischemic postconditioning (IPostC) has been proved to have neuroprotective effects for cerebral ischemia, but the underlying mechanism remains elusive. This study aimed at validating the neuroprotective effects of IPostC and investigating whether the neuroprotection of IPostC is associated with matrix metalloproteinase 9 (MMP9) and the extracellular matrix proteins, laminin and fibronectin, following cerebral ischemia/reperfusion in rats. Methods The rats in middle cerebral artery occlusion (MCAO) group underwent MCAO and reperfusion, and the animals in MCAO + IPostC group were treated by occluding bilateral common carotid arteries for 10 seconds and then reperfusing for 10 seconds for five episodes at the beginning of MCAO. Apoptosis was detected with terminal deoxynucleotidyl transferase dUTP nick end labeling staining. The expression of MMP9, laminin, and fibronectin was measured with immunofluorescence and enzyme-linked immunosorbent assay. Results IPostC reduced brain edema and infarct volume and improved the neurological function. Furthermore, IPostC decreased cell apoptosis compared with the MCAO group. Compared to the MCAO group, IPostC treatment reduced MMP9 expression. Moreover, the results showed that the expression of laminin and fibronectin significantly increased in the MCAO + IPostC group compared to the MCAO group. Conclusion These findings indicated that diminishment of MMP9 expression and the attenuation of degradation of laminin and fibronectin may be involved in the protective mechanisms of postconditioning against cerebral ischemia/reperfusion injury.
PI3K-Akt/eNOS in remote postconditioning induced by brief pulmonary ischemia

Yan-hua Tang,Jue-shen Yang,Hai-yan Xiang,Jia-jun Xu

DOI: https://doi.org/10.25011/cim.v37i1.20866

2014-02-01

Abstract:Purpose: Postconditioning, a series of brief ischemia-reperfusion sequences given before an ischemic heart undergoes sustained reperfusion, has been shown to lessen ischemia/reperfusion injury. The current study establishes a rabbit model of myocardial ischemia-reperfusion and studied the effects of pulmonary remote postconditioning in this model. Methods: Serum levels of creatine kinase (CK), superoxide dismutase (SOD), and malondialdehyde (MDA), protein expression of endothelial nitric oxide synthase (eNOS), Rho kinase (ROCK- 2), and protein kinase B (Akt) in myocardial cells and the apoptosis index of myocardial cells were examined. Results: Pulmonary remote postconditioning decreased CK, significantly decreased MDA, and increased SOD. Postconditioning significantly increased eNOS protein expression. Administration of eNOS inhibitor, L-NAME, dramatically suppressed the postconditioning-induced eNOS protein expression and serum SOD level, but significantly increased MDA level. The two longer sessions of postconditioning increased Akt, although this increase was not accompanied by changes in levels of the Akt inhibitor, ROCK-2. Blocking eNOS activity with L-NAME had no visible effect on either Akt or ROCK-2. Conclusion: Our results suggest a role for Akt in remote postconditioning-induced myocardial protection, but do not support an involvement of eNOS in Akt-mediated action.
Valosin-containing protein acts as a target and mediator of S-nitrosylation in the heart through distinct mechanisms

Xiaomeng Shi,Molly O’Connor,Hongyu Qiu

DOI: https://doi.org/10.1016/j.redox.2024.103166

IF: 11.4

2024-04-27

Redox Biology

Abstract:S-nitrosylation (SNO) is an emerging paradigm of redox signaling protecting cells against oxidative stress in the heart. Our previous studies demonstrated that valosin-containing protein (VCP), an ATPase-associated protein, is a vital mediator protecting the heart against cardiac stress and ischemic injury. However, the molecular regulations conferred by VCP in the heart are not fully understood. In this study, we explored the potential role of VCP in cardiac protein SNO using multiple cardiac-specific genetically modified mouse models and various analytical techniques including biotin switch assay, liquid chromatography, mass spectrometry, and western blotting. Our results showed that cardiac-specific overexpression of VCP led to an overall increase in the levels of SNO-modified cardiac proteins in the transgenic (TG) vs. WT mice. Mass spectrometry analysis identified mitochondrial proteins involved in respiration, metabolism, and detoxification as primary targets of SNO modification in VCP-overexpressing mouse hearts. Particularly, we found that VCP itself underwent SNO modification at a specific cysteine residue in its N-domain. Additionally, our study demonstrated that glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a key enzyme in glycolysis, also experienced increased SNO in response to VCP overexpression. While deletion of inducible nitric oxide synthase (iNOS) in VCP TG mice did not affect VCP SNO, it did abolish SNO modification in mitochondrial complex proteins, suggesting a dual mechanism of regulation involving both iNOS-dependent and independent pathways. Overall, our findings shed light on post-translational modification of VCP in the heart, unveiling a previously unrecognized role for VCP in regulating cardiac protein SNO and offering new insights into its function in cardiac protection.

biochemistry & molecular biology
Effects of ischemic postconditioning and preconditioning induced by Nicorandil on myocardial ischemia/reperfusion injury in isolated rat heart

LU Xin,LIU Li-qun,CHEN Wei-ning,CUI Yu-qian,WANG Shi-zhong,DU Cai-ju

DOI: https://doi.org/10.3969/j.issn.1674-0785.2007.06.010

2007-01-01

Abstract:Objective To explore the effect of Nicorandil postconditioning and preconditioning and synergistic effect of both on myocardial I/R injury in isolated rat heart for measurement of the area at risk of infarction,biochemical indicator of effluent and hemodynamics index of cardiac function.Methods Langendorff isolated perfused rat heart were subjected to 30 min of local ischemia followed by 120 min reperfusion.All hearts were randomly divided into 6 groups.(1)(group CON)Control hearts underwent no additional intervention;(2)(group POS)Postconditioning consisted of 6 episodes of 10 seconds(s)of left anterior descending branch(LAD)occlusion and 10 s of reperfusion performed before full restoration of flow;(3)(group NPO)Nicorandil postconditioning group:the hearts were dealt as group CON,but during the reperfusion period the hearts were reperfused with liquid including Nicorandil(20 μmol/L)for 10 min,and followed by 120 min of reperfusion;(4)(group IPC)Nicorandil preconditioning was achieved by reperfusing liquid that contained Nicorandil for 10 min before the ischemic;(5)(group NPP):Nicorandil preconditioning combined with Nicorandil postconditioning;(6)(group GNP):the hearts were dealt as Npp but the liquid including glibenclamide(Gli:20 μmol/L).Observed indexes include:1)recovery of cardiac function including Lvdp,±dp/dt;2)coronary flow(CF);3)myocardial CK leakage and LDH in the effluent from the isolated perfused heart;5)The myocardial infarct size were evaluated by TTC staining.Results Cardioprotective effect in POS,NPO,IPC and NPP significantly improved LVDP and ±dP/dt and increased CF.Gli abolished the improvement of cardiac function and CF.POS,NPO,IPC and NPP showed less the dosage of CK leakage and LDH,but there was not statistical difference between group CON and GNP.IPC reduced infarct size from(50.02±2.9)% to(22.72±3.6)%(P<0.05),the protective effect in NPP and NPO reduced the infarct size respectively(23.99±4.3)% and(29.02±2.1)%(P<0.05),POS reduced protective effect that reduced the infarct size to(34.63±4.1)%(P<0.05),Gli completely abolished Nicorandil-induced protection to(46.82±6.69)%.Conclusions In this model,ischemic postconditioning,Nicorandil preconditioning,Nicorandil postconditioning and combination of both conditioning can protect the I/R injury myocardium,of interest,the combined protective effects of NPP were not additive.The activation of ATP-sensitive potassium channels played an important role in Nicorandil dealt in I/R injury in isolated rat heart.

Microvascular reactivity of in vitro blood perfused juxtamedullary nephrons from rats.

Zinc Finger Nucleases as tools to understand and treat human diseases

[Angiotensin-Converting Enzyme Inhibitors Potentiate Subthreshold Preconditioning Through NO and Mitok(atp) Channel.].

Cardioprotection of Ischemic Postconditioning Against Ischemia/reperfusion Injury in Isolated Rat Hearts

[COX-2 or Nnos Mediates Cardioprotection During the Final Stage of the Late Phase of Ischemic Preconditioning].

Ischemic Postconditioning Protects the Heart Against Ischemia–reperfusion Injury Via Neuronal Nitric Oxide Synthase in the Sarcoplasmic Reticulum and Mitochondria

Increased protein S-nitrosylation in mitochondria: a key mechanism of exercise-induced cardioprotection

Abstract W P109: Nitrosative Stress Preconditioning Ameliorated Neurovascular Injury in Stroke

Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model.

Abstract 4146997: S-nitrosylation of Aconitase-2 Facilitates Coronary Microembolization-induced Cardiac Injury by Suppressing Iron-sulfur Cluster Assembly

S-nitrosylation of Aconitase-2 Facilitates Coronary Microembolization-Induced Cardiac Injury by Suppressing Iron-Sulfur Cluster Assembly

Pretreatment with the nitric oxide donor SNAP or nerve transection blocks humoral preconditioning by remote limb ischemia or intra-arterial adenosine

Cardioprotective PKG-independent NO signaling at reperfusion

Ischemic Postconditioning Relieves Cerebral Ischemia and Reperfusion Injury Through Activating T-LAK Cell–Originated Protein Kinase/Protein Kinase B Pathway in Rats

Nitric Oxide Regulation of Myocardial O-2 Consumption and Hep Metabolism

The dynamic detection of NO during the ischemic postconditioning against global cerebral ischemia/reperfusion injury.

S-nitrosylation of AMPKγ impairs coronary collateral circulation and disrupts VSMC reprogramming

Ischemic Postconditioning Diminishes Matrix Metalloproteinase 9 Expression and Attenuates Loss of the Extracellular Matrix Proteins in Rats Following Middle Cerebral Artery Occlusion and Reperfusion

PI3K-Akt/eNOS in remote postconditioning induced by brief pulmonary ischemia

Valosin-containing protein acts as a target and mediator of S-nitrosylation in the heart through distinct mechanisms

Effects of ischemic postconditioning and preconditioning induced by Nicorandil on myocardial ischemia/reperfusion injury in isolated rat heart